Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
MINNEAPOLIS, MINNESOTA--(Marketwired - Nov. 28, 2016) - DiaMedica Inc. (TSX VENTURE:DMA)(OTCQB:DMCAF) (the "Company"), today announced that at its Annual General and Special Meeting (the...
-
MINNEAPOLIS, MINNESOTA--(Marketwired - Oct. 12, 2016) - DiaMedica Inc. (the "Company") (TSX VENTURE:DMA)(OTCQB:DMCAF) today announced the establishment of a Scientific Advisory Board...
-
MINNEAPOLIS, MINNESOTA--(Marketwired - Oct. 5, 2016) - DiaMedica Inc. (the "Company") (TSX VENTURE:DMA)(OTCQB:DMCAF) announced that the first patient has been dosed in the Phase Ib...
-
MINNEAPOLIS, MINNESOTA--(Marketwired - Sept. 26, 2016) - DiaMedica Inc. (the "Company") (TSX VENTURE:DMA)(OTCQB:DMCAF), a biopharmaceutical company developing novel treatments for...
-
MINNEAPOLIS, MINNESOTA--(Marketwired - Sept. 12, 2016) - DiaMedica Inc. (the "Company") (TSX VENTURE:DMA)(OTCQB:DMCAF) DiaMedica announced that it has received regulatory clearance in...
-
WINNIPEG, MANITOBA and MINNEAPOLIS, MINNESOTA--(Marketwired - Sept. 8, 2016) - DiaMedica Inc. (the "Company") (TSX VENTURE:DMA)(OTCQB:DMCAF) is pleased to announce that it has closed the...
-
WINNIPEG, MANITOBA and MINNEAPOLIS, MINNESOTA--(Marketwired - Aug. 22, 2016) - DiaMedica Inc. (the "Company") (TSX VENTURE:DMA)(OTCQB:DMCAF) is pleased to announce that it has closed the...
-
WINNIPEG, MANITOBA and MINNEAPOLIS, MINNESOTA--(Marketwired - July 17, 2016) - DiaMedica Inc. (the "Company") (TSX VENTURE:DMA)(OTCQB:DMCAF), today announced a strategic investment with...
-
MINNEAPOLIS, MINNESOTA--(Marketwired - June 14, 2016) - DiaMedica Inc. (the "Company") (TSX VENTURE:DMA)(OTCQB:DMCAF), today announced that the U.S. Patent and Trademark Office has issued...
-
MINNEAPOLIS, MINNESOTA--(Marketwired - May 9, 2016) - DiaMedica Inc. (the "Company") (TSX VENTURE:DMA)(OTCQB:DMCAF) today announced the appointment of Dr. Todd Verdoorn as the Company's...